Cargando…
Clinical Cellular Therapeutics Accelerate Clot Formation
Clinical cellular therapeutics (CCTs) have shown preliminary efficacy in reducing inflammation after trauma, preserving cardiac function after myocardial infarction, and improving functional recovery after stroke. However, most clinically available cell lines express tissue factor (TF) which stimula...
Autores principales: | George, Mitchell J., Prabhakara, Karthik, Toledano‐Furman, Naama E., Wang, Yao‐Wei, Gill, Brijesh S., Wade, Charles E., Olson, Scott D., Cox, Charles S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186273/ https://www.ncbi.nlm.nih.gov/pubmed/30070065 http://dx.doi.org/10.1002/sctm.18-0015 |
Ejemplares similares
-
Procoagulant in vitro effects of clinical cellular therapeutics in a severely injured trauma population
por: George, Mitchell J., et al.
Publicado: (2020) -
Mesenchymal Stromal Cell Therapeutic Delivery: Translational Challenges to Clinical Application
por: Caplan, Henry, et al.
Publicado: (2019) -
Human-derived Treg and MSC combination therapy may augment immunosuppressive potency in vitro, but did not improve blood brain barrier integrity in an experimental rat traumatic brain injury model
por: Caplan, Henry W., et al.
Publicado: (2021) -
Time dependent analysis of rat microglial surface markers in traumatic brain injury reveals dynamics of distinct cell subpopulations
por: Gottlieb, Assaf, et al.
Publicado: (2022) -
Human Mesenchymal Stromal Cell-Derived Extracellular Vesicles Modify Microglial Response and Improve Clinical Outcomes in Experimental Spinal Cord Injury
por: Ruppert, Katherine A., et al.
Publicado: (2018)